サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120773

世界のヒアルロニダーゼ市場：考察と予測 (2028年まで)

Global Hyaluronidase Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 125 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
世界のヒアルロニダーゼ市場：考察と予測 (2028年まで)
出版日: 2022年08月31日
発行: QYResearch
ページ情報: 英文 125 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ヒアルロニダーゼ (Hyaluronidase) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • ヒアルロニダーゼの製品概要
  • 市場：タイプ別
    • 世界のヒアルロニダーゼの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Animal-derived Hyaluronidase
    • Synthetic Hyaluronidase
  • 市場：アプリケーション別
    • 世界のヒアルロニダーゼの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Dermatology
    • Plastic Surgery
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のヒアルロニダーゼの販売 推定および予測 2017-2028
  • 世界のヒアルロニダーゼの収益 推定および予測 2017-2028
  • 世界のヒアルロニダーゼの収益：地域別: 2017 VS 2021 VS 2028
  • 世界のヒアルロニダーゼの販売：地域別
    • 世界のヒアルロニダーゼの販売：地域別 (2017-2022)
    • 世界の販売 ヒアルロニダーゼ ：地域別 (2023-2028)
  • 世界のヒアルロニダーゼの収益：地域別
    • 世界のヒアルロニダーゼの収益：地域別 (2017-2022)
    • 世界のヒアルロニダーゼの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界のヒアルロニダーゼの販売：メーカー別
    • 世界のヒアルロニダーゼの上位メーカー：販売別 (2017-2022)
    • 世界のヒアルロニダーゼの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： ヒアルロニダーゼ2021
  • 世界のヒアルロニダーゼの収益：メーカー別
    • 世界のヒアルロニダーゼの収益：メーカー別 (2017-2022)
    • 世界のヒアルロニダーゼの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： ヒアルロニダーゼの収益 2021
  • 世界のヒアルロニダーゼの販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のヒアルロニダーゼの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のヒアルロニダーゼのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のヒアルロニダーゼの販売：タイプ別
    • 世界のヒアルロニダーゼの販売実績：タイプ別 (2017-2022)
    • 世界のヒアルロニダーゼの販売予測：タイプ別 (2023-2028)
    • 世界のヒアルロニダーゼの販売市場シェア：タイプ別 (2017-2028)
  • 世界のヒアルロニダーゼの収益：タイプ別
    • 世界のヒアルロニダーゼの収益実績：タイプ別 (2017-2022)
    • 世界のヒアルロニダーゼの収益予測：タイプ別 (2023-2028)
    • 世界のヒアルロニダーゼの収益市場シェア：タイプ別 (2017-2028)
  • 世界のヒアルロニダーゼの価格：タイプ別
    • 世界のヒアルロニダーゼの価格：タイプ別 (2017-2022)
    • 世界のヒアルロニダーゼの価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界のヒアルロニダーゼの販売：アプリケーション別
    • 世界のヒアルロニダーゼの販売実績：アプリケーション別 (2017-2022)
    • 世界のヒアルロニダーゼの販売予測：アプリケーション別 (2023-2028)
    • 世界のヒアルロニダーゼの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のヒアルロニダーゼの収益：アプリケーション別
    • 世界のヒアルロニダーゼの収益実績：アプリケーション別 (2017-2022)
    • 世界のヒアルロニダーゼの収益予測：アプリケーション別 (2023-2028)
    • 世界のヒアルロニダーゼの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のヒアルロニダーゼの価格：アプリケーション別
    • 世界のヒアルロニダーゼの価格：アプリケーション別 (2017-2022)
    • 世界のヒアルロニダーゼの価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のヒアルロニダーゼ 市場規模：タイプ別
    • 北米のヒアルロニダーゼの販売：タイプ別 (2017-2028)
    • 北米のヒアルロニダーゼの収益：タイプ別 (2017-2028)
  • 北米のヒアルロニダーゼ 市場規模：アプリケーション別
    • 北米のヒアルロニダーゼの販売：アプリケーション別 (2017-2028)
    • 北米のヒアルロニダーゼの収益：アプリケーション別 (2017-2028)
  • 北米のヒアルロニダーゼ 市場規模：国別
    • 北米のヒアルロニダーゼの販売：国別 (2017-2028)
    • 北米のヒアルロニダーゼの収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のヒアルロニダーゼ 市場規模：タイプ別
    • 欧州のヒアルロニダーゼの販売：タイプ別 (2017-2028)
    • 欧州のヒアルロニダーゼの収益：タイプ別 (2017-2028)
  • 欧州のヒアルロニダーゼ 市場規模：アプリケーション別
    • 欧州のヒアルロニダーゼの販売：アプリケーション別 (2017-2028)
    • 欧州のヒアルロニダーゼの収益：アプリケーション別 (2017-2028)
  • 欧州のヒアルロニダーゼ 市場規模：国別
    • 欧州のヒアルロニダーゼの販売：国別 (2017-2028)
    • 欧州のヒアルロニダーゼの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のヒアルロニダーゼ 市場規模：タイプ別
    • アジア太平洋のヒアルロニダーゼの販売：タイプ別 (2017-2028)
    • アジア太平洋のヒアルロニダーゼの収益：タイプ別 (2017-2028)
  • アジア太平洋のヒアルロニダーゼ 市場規模：アプリケーション別
    • アジア太平洋のヒアルロニダーゼの販売：アプリケーション別 (2017-2028)
    • アジア太平洋のヒアルロニダーゼの収益：アプリケーション別 (2017-2028)
  • アジア太平洋のヒアルロニダーゼ 市場規模：地域別
    • アジア太平洋のヒアルロニダーゼの販売：地域別 (2017-2028)
    • アジア太平洋のヒアルロニダーゼの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカのヒアルロニダーゼ 市場規模：タイプ別
    • ラテンアメリカのヒアルロニダーゼの販売：タイプ別 (2017-2028)
    • ラテンアメリカのヒアルロニダーゼの収益：タイプ別 (2017-2028)
  • ラテンアメリカのヒアルロニダーゼ 市場規模：アプリケーション別
    • ラテンアメリカのヒアルロニダーゼの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのヒアルロニダーゼの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのヒアルロニダーゼ 市場規模：国別
    • ラテンアメリカのヒアルロニダーゼの販売：国別 (2017-2028)
    • ラテンアメリカのヒアルロニダーゼの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのヒアルロニダーゼ 市場規模：タイプ別
    • 中東・アフリカのヒアルロニダーゼの販売：タイプ別 (2017-2028)
    • 中東・アフリカのヒアルロニダーゼの収益：タイプ別 (2017-2028)
  • 中東・アフリカのヒアルロニダーゼ 市場規模：アプリケーション別
    • 中東・アフリカのヒアルロニダーゼの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのヒアルロニダーゼの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのヒアルロニダーゼ 市場規模：国別
    • 中東・アフリカのヒアルロニダーゼの販売：国別 (2017-2028)
    • 中東・アフリカのヒアルロニダーゼの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • PrimaPharm
  • Bausch Health
  • Amphastar Pharmaceuticals
  • Halozyme Therapeutics
  • CooperSurgical Fertility
  • Shreya Life Sciences
  • Sun Pharmaceutical Industries
  • CBC Pharma
  • STEMCELL Technologies

第12章 業界チェーンと販売チャネルの分析

  • ヒアルロニダーゼ 業界チェーン分析
  • ヒアルロニダーゼ 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • ヒアルロニダーゼ 生産形態とプロセス
  • ヒアルロニダーゼ 販売およびマーケティング
    • ヒアルロニダーゼ 販売チャネル
    • ヒアルロニダーゼ 卸業者
  • ヒアルロニダーゼ 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • ヒアルロニダーゼ 業界動向
  • ヒアルロニダーゼ 市場の促進要因
  • ヒアルロニダーゼ 市場の課題
  • ヒアルロニダーゼ 市場の抑制要因

第14章 世界のヒアルロニダーゼの主な市場調査結果

第15章 付録

図表
  • Table 1. Global Hyaluronidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Animal-derived Hyaluronidase
  • Table 3. Major Manufacturers of Synthetic Hyaluronidase
  • Table 4. Global Hyaluronidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Hyaluronidase Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Hyaluronidase Sales by Region (2017-2022) & (L)
  • Table 7. Global Hyaluronidase Sales Market Share by Region (2017-2022)
  • Table 8. Global Hyaluronidase Sales by Region (2023-2028) & (L)
  • Table 9. Global Hyaluronidase Sales Market Share by Region (2023-2028)
  • Table 10. Global Hyaluronidase Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Hyaluronidase Revenue Market Share by Region (2017-2022)
  • Table 12. Global Hyaluronidase Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Hyaluronidase Revenue Market Share by Region (2023-2028)
  • Table 14. Global Hyaluronidase Sales by Manufacturers (2017-2022) & (L)
  • Table 15. Global Hyaluronidase Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Hyaluronidase Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Hyaluronidase Revenue Share by Manufacturers (2017-2022)
  • Table 18. Hyaluronidase Price by Manufacturers (2017-2022) &(USD/mL)
  • Table 19. Global Hyaluronidase Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Hyaluronidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyaluronidase as of 2021)
  • Table 21. Hyaluronidase Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Hyaluronidase Product Offered
  • Table 23. Date of Manufacturers Enter into Hyaluronidase Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 26. Global Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 27. Global Hyaluronidase Sales Share by Type (2017-2022)
  • Table 28. Global Hyaluronidase Sales Share by Type (2023-2028)
  • Table 29. Global Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Hyaluronidase Revenue Share by Type (2017-2022)
  • Table 32. Global Hyaluronidase Revenue Share by Type (2023-2028)
  • Table 33. Hyaluronidase Price by Type (2017-2022) & (USD/mL)
  • Table 34. Global Hyaluronidase Price Forecast by Type (2023-2028) & (USD/mL)
  • Table 35. Global Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 36. Global Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 37. Global Hyaluronidase Sales Share by Application (2017-2022)
  • Table 38. Global Hyaluronidase Sales Share by Application (2023-2028)
  • Table 39. Global Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Hyaluronidase Revenue Share by Application (2017-2022)
  • Table 42. Global Hyaluronidase Revenue Share by Application (2023-2028)
  • Table 43. Hyaluronidase Price by Application (2017-2022) & (USD/mL)
  • Table 44. Global Hyaluronidase Price Forecast by Application (2023-2028) & (USD/mL)
  • Table 45. North America Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 46. North America Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 47. North America Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 50. North America Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 51. North America Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Hyaluronidase Sales by Country (2017-2022) & (L)
  • Table 54. North America Hyaluronidase Sales by Country (2023-2028) & (L)
  • Table 55. North America Hyaluronidase Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Hyaluronidase Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 58. Europe Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 59. Europe Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 62. Europe Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 63. Europe Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Hyaluronidase Sales by Country (2017-2022) & (L)
  • Table 66. Europe Hyaluronidase Sales by Country (2023-2028) & (L)
  • Table 67. Europe Hyaluronidase Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Hyaluronidase Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 70. Asia Pacific Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 71. Asia Pacific Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 74. Asia Pacific Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 75. Asia Pacific Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Hyaluronidase Sales by Region (2017-2022) & (L)
  • Table 78. Asia Pacific Hyaluronidase Sales by Region (2023-2028) & (L)
  • Table 79. Asia Pacific Hyaluronidase Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Hyaluronidase Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 82. Latin America Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 83. Latin America Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 86. Latin America Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 87. Latin America Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Hyaluronidase Sales by Country (2017-2022) & (L)
  • Table 90. Latin America Hyaluronidase Sales by Country (2023-2028) & (L)
  • Table 91. Latin America Hyaluronidase Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Hyaluronidase Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Hyaluronidase Sales by Type (2017-2022) & (L)
  • Table 94. Middle East and Africa Hyaluronidase Sales by Type (2023-2028) & (L)
  • Table 95. Middle East and Africa Hyaluronidase Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Hyaluronidase Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Hyaluronidase Sales by Application (2017-2022) & (L)
  • Table 98. Middle East and Africa Hyaluronidase Sales by Application (2023-2028) & (L)
  • Table 99. Middle East and Africa Hyaluronidase Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Hyaluronidase Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Hyaluronidase Sales by Country (2017-2022) & (L)
  • Table 102. Middle East and Africa Hyaluronidase Sales by Country (2023-2028) & (L)
  • Table 103. Middle East and Africa Hyaluronidase Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Hyaluronidase Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. PrimaPharm Corporation Information
  • Table 106. PrimaPharm Description and Major Businesses
  • Table 107. PrimaPharm Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 108. PrimaPharm Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. PrimaPharm Recent Developments
  • Table 110. Bausch Health Corporation Information
  • Table 111. Bausch Health Description and Major Businesses
  • Table 112. Bausch Health Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 113. Bausch Health Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Bausch Health Recent Developments
  • Table 115. Amphastar Pharmaceuticals Corporation Information
  • Table 116. Amphastar Pharmaceuticals Description and Major Businesses
  • Table 117. Amphastar Pharmaceuticals Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 118. Amphastar Pharmaceuticals Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Amphastar Pharmaceuticals Recent Developments
  • Table 120. Halozyme Therapeutics Corporation Information
  • Table 121. Halozyme Therapeutics Description and Major Businesses
  • Table 122. Halozyme Therapeutics Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 123. Halozyme Therapeutics Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Halozyme Therapeutics Recent Developments
  • Table 125. CooperSurgical Fertility Corporation Information
  • Table 126. CooperSurgical Fertility Description and Major Businesses
  • Table 127. CooperSurgical Fertility Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 128. CooperSurgical Fertility Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. CooperSurgical Fertility Recent Developments
  • Table 130. Shreya Life Sciences Corporation Information
  • Table 131. Shreya Life Sciences Description and Major Businesses
  • Table 132. Shreya Life Sciences Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 133. Shreya Life Sciences Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Shreya Life Sciences Recent Developments
  • Table 135. Sun Pharmaceutical Industries Corporation Information
  • Table 136. Sun Pharmaceutical Industries Description and Major Businesses
  • Table 137. Sun Pharmaceutical Industries Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 138. Sun Pharmaceutical Industries Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Sun Pharmaceutical Industries Recent Developments
  • Table 140. CBC Pharma Corporation Information
  • Table 141. CBC Pharma Description and Major Businesses
  • Table 142. CBC Pharma Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 143. CBC Pharma Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. CBC Pharma Recent Developments
  • Table 145. STEMCELL Technologies Corporation Information
  • Table 146. STEMCELL Technologies Description and Major Businesses
  • Table 147. STEMCELL Technologies Hyaluronidase Sales (L), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2017-2022)
  • Table 148. STEMCELL Technologies Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 149. STEMCELL Technologies Recent Developments
  • Table 150. Key Raw Materials Lists
  • Table 151. Raw Materials Key Suppliers Lists
  • Table 152. Hyaluronidase Distributors List
  • Table 153. Hyaluronidase Customers List
  • Table 154. Hyaluronidase Market Trends
  • Table 155. Hyaluronidase Market Drivers
  • Table 156. Hyaluronidase Market Challenges
  • Table 157. Hyaluronidase Market Restraints
  • Table 158. Research Programs/Design for This Report
  • Table 159. Key Data Information from Secondary Sources
  • Table 160. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Hyaluronidase Product Picture
  • Figure 3. Global Hyaluronidase Market Share by Type in 2021 & 2028
  • Figure 3. Animal-derived Hyaluronidase Product Picture
  • Figure 4. Synthetic Hyaluronidase Product Picture
  • Figure 5. Global Hyaluronidase Market Share by Application in 2021 & 2028
  • Figure 6. Dermatology
  • Figure 7. Plastic Surgery
  • Figure 8. Hyaluronidase Report Years Considered
  • Figure 9. Global Hyaluronidase Sales 2017-2028 (L)
  • Figure 10. Global Hyaluronidase Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Hyaluronidase Revenue 2017-2028 (US$ Million)
  • Figure 12. Global Hyaluronidase Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 13. Global Hyaluronidase Sales Market Share by Region (2017-2022)
  • Figure 14. Global Hyaluronidase Sales Market Share by Region (2023-2028)
  • Figure 15. North America Hyaluronidase Sales YoY (2017-2028) & (L)
  • Figure 16. North America Hyaluronidase Revenue YoY (2017-2028) & (US$ Million)
  • Figure 17. Europe Hyaluronidase Sales YoY (2017-2028) & (L)
  • Figure 18. Europe Hyaluronidase Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Asia-Pacific Hyaluronidase Sales YoY (2017-2028) & (L)
  • Figure 20. Asia-Pacific Hyaluronidase Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Latin America Hyaluronidase Sales YoY (2017-2028) & (L)
  • Figure 22. Latin America Hyaluronidase Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Middle East & Africa Hyaluronidase Sales YoY (2017-2028) & (L)
  • Figure 24. Middle East & Africa Hyaluronidase Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. The Hyaluronidase Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 26. The Top 5 and 10 Largest Manufacturers of Hyaluronidase in the World: Market Share by Hyaluronidase Revenue in 2021
  • Figure 27. Global Hyaluronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 28. Global Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 29. Global Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 30. Global Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 31. Global Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 32. North America Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 33. North America Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 34. North America Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 35. North America Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 36. North America Hyaluronidase Sales Share by Country (2017-2028)
  • Figure 37. North America Hyaluronidase Revenue Share by Country (2017-2028)
  • Figure 38. U.S. Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 39. Canada Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 40. Europe Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 41. Europe Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 42. Europe Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 43. Europe Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 44. Europe Hyaluronidase Sales Share by Country (2017-2028)
  • Figure 45. Europe Hyaluronidase Revenue Share by Country (2017-2028)
  • Figure 46. Germany Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 47. France Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 48. U.K. Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 49. Italy Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 50. Russia Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 51. Asia Pacific Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 52. Asia Pacific Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 54. Asia Pacific Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Hyaluronidase Sales Share by Region (2017-2028)
  • Figure 56. Asia Pacific Hyaluronidase Revenue Share by Region (2017-2028)
  • Figure 57. China Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 58. Japan Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 59. South Korea Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 60. India Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 61. Australia Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 62. Taiwan Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 63. Indonesia Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 64. Thailand Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 65. Malaysia Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 66. Philippines Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 67. Latin America Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 68. Latin America Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 69. Latin America Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 70. Latin America Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 71. Latin America Hyaluronidase Sales Share by Country (2017-2028)
  • Figure 72. Latin America Hyaluronidase Revenue Share by Country (2017-2028)
  • Figure 73. Mexico Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 74. Brazil Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 75. Argentina Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 76. Middle East and Africa Hyaluronidase Sales Market Share by Type (2017-2028)
  • Figure 77. Middle East and Africa Hyaluronidase Revenue Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Hyaluronidase Sales Market Share by Application (2017-2028)
  • Figure 79. Middle East and Africa Hyaluronidase Revenue Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Hyaluronidase Sales Share by Country (2017-2028)
  • Figure 81. Middle East and Africa Hyaluronidase Revenue Share by Country (2017-2028)
  • Figure 82. Turkey Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 83. Saudi Arabia Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 84. U.A.E Hyaluronidase Revenue (2017-2028) & (US$ Million)
  • Figure 85. Hyaluronidase Value Chain
  • Figure 86. Hyaluronidase Production Process
  • Figure 87. Channels of Distribution
  • Figure 88. Distributors Profiles
  • Figure 89. Bottom-up and Top-down Approaches for This Report
  • Figure 90. Data Triangulation
  • Figure 91. Key Executives Interviewed
目次

This research report focuses on the Hyaluronidase Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Hyaluronidase Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Hyaluronidase Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Animal-derived Hyaluronidase
    • 1.2.3 Synthetic Hyaluronidase
  • 1.3 Market by Application
    • 1.3.1 Global Hyaluronidase Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Dermatology
    • 1.3.3 Plastic Surgery
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Hyaluronidase Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Hyaluronidase Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Hyaluronidase Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Hyaluronidase Sales by Region
    • 2.4.1 Global Hyaluronidase Sales by Region (2017-2022)
    • 2.4.2 Global Sales Hyaluronidase by Region (2023-2028)
  • 2.5 Global Hyaluronidase Revenue by Region
    • 2.5.1 Global Hyaluronidase Revenue by Region (2017-2022)
    • 2.5.2 Global Hyaluronidase Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Hyaluronidase Sales by Manufacturers
    • 3.1.1 Global Top Hyaluronidase Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Hyaluronidase Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hyaluronidase in 2021
  • 3.2 Global Hyaluronidase Revenue by Manufacturers
    • 3.2.1 Global Hyaluronidase Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Hyaluronidase Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Hyaluronidase Revenue in 2021
  • 3.3 Global Hyaluronidase Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Hyaluronidase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Hyaluronidase Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Hyaluronidase Sales by Type
    • 4.1.1 Global Hyaluronidase Historical Sales by Type (2017-2022)
    • 4.1.2 Global Hyaluronidase Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Hyaluronidase Sales Market Share by Type (2017-2028)
  • 4.2 Global Hyaluronidase Revenue by Type
    • 4.2.1 Global Hyaluronidase Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Hyaluronidase Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Hyaluronidase Revenue Market Share by Type (2017-2028)
  • 4.3 Global Hyaluronidase Price by Type
    • 4.3.1 Global Hyaluronidase Price by Type (2017-2022)
    • 4.3.2 Global Hyaluronidase Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Hyaluronidase Sales by Application
    • 5.1.1 Global Hyaluronidase Historical Sales by Application (2017-2022)
    • 5.1.2 Global Hyaluronidase Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Hyaluronidase Sales Market Share by Application (2017-2028)
  • 5.2 Global Hyaluronidase Revenue by Application
    • 5.2.1 Global Hyaluronidase Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Hyaluronidase Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Hyaluronidase Revenue Market Share by Application (2017-2028)
  • 5.3 Global Hyaluronidase Price by Application
    • 5.3.1 Global Hyaluronidase Price by Application (2017-2022)
    • 5.3.2 Global Hyaluronidase Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Hyaluronidase Market Size by Type
    • 6.1.1 North America Hyaluronidase Sales by Type (2017-2028)
    • 6.1.2 North America Hyaluronidase Revenue by Type (2017-2028)
  • 6.2 North America Hyaluronidase Market Size by Application
    • 6.2.1 North America Hyaluronidase Sales by Application (2017-2028)
    • 6.2.2 North America Hyaluronidase Revenue by Application (2017-2028)
  • 6.3 North America Hyaluronidase Market Size by Country
    • 6.3.1 North America Hyaluronidase Sales by Country (2017-2028)
    • 6.3.2 North America Hyaluronidase Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Hyaluronidase Market Size by Type
    • 7.1.1 Europe Hyaluronidase Sales by Type (2017-2028)
    • 7.1.2 Europe Hyaluronidase Revenue by Type (2017-2028)
  • 7.2 Europe Hyaluronidase Market Size by Application
    • 7.2.1 Europe Hyaluronidase Sales by Application (2017-2028)
    • 7.2.2 Europe Hyaluronidase Revenue by Application (2017-2028)
  • 7.3 Europe Hyaluronidase Market Size by Country
    • 7.3.1 Europe Hyaluronidase Sales by Country (2017-2028)
    • 7.3.2 Europe Hyaluronidase Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Hyaluronidase Market Size by Type
    • 8.1.1 Asia Pacific Hyaluronidase Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Hyaluronidase Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Hyaluronidase Market Size by Application
    • 8.2.1 Asia Pacific Hyaluronidase Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Hyaluronidase Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Hyaluronidase Market Size by Region
    • 8.3.1 Asia Pacific Hyaluronidase Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Hyaluronidase Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Hyaluronidase Market Size by Type
    • 9.1.1 Latin America Hyaluronidase Sales by Type (2017-2028)
    • 9.1.2 Latin America Hyaluronidase Revenue by Type (2017-2028)
  • 9.2 Latin America Hyaluronidase Market Size by Application
    • 9.2.1 Latin America Hyaluronidase Sales by Application (2017-2028)
    • 9.2.2 Latin America Hyaluronidase Revenue by Application (2017-2028)
  • 9.3 Latin America Hyaluronidase Market Size by Country
    • 9.3.1 Latin America Hyaluronidase Sales by Country (2017-2028)
    • 9.3.2 Latin America Hyaluronidase Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Hyaluronidase Market Size by Type
    • 10.1.1 Middle East and Africa Hyaluronidase Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Hyaluronidase Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Hyaluronidase Market Size by Application
    • 10.2.1 Middle East and Africa Hyaluronidase Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Hyaluronidase Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Hyaluronidase Market Size by Country
    • 10.3.1 Middle East and Africa Hyaluronidase Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Hyaluronidase Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 PrimaPharm
    • 11.1.1 PrimaPharm Corporation Information
    • 11.1.2 PrimaPharm Overview
    • 11.1.3 PrimaPharm Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 PrimaPharm Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 PrimaPharm Recent Developments
  • 11.2 Bausch Health
    • 11.2.1 Bausch Health Corporation Information
    • 11.2.2 Bausch Health Overview
    • 11.2.3 Bausch Health Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Bausch Health Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Bausch Health Recent Developments
  • 11.3 Amphastar Pharmaceuticals
    • 11.3.1 Amphastar Pharmaceuticals Corporation Information
    • 11.3.2 Amphastar Pharmaceuticals Overview
    • 11.3.3 Amphastar Pharmaceuticals Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Amphastar Pharmaceuticals Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Amphastar Pharmaceuticals Recent Developments
  • 11.4 Halozyme Therapeutics
    • 11.4.1 Halozyme Therapeutics Corporation Information
    • 11.4.2 Halozyme Therapeutics Overview
    • 11.4.3 Halozyme Therapeutics Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Halozyme Therapeutics Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Halozyme Therapeutics Recent Developments
  • 11.5 CooperSurgical Fertility
    • 11.5.1 CooperSurgical Fertility Corporation Information
    • 11.5.2 CooperSurgical Fertility Overview
    • 11.5.3 CooperSurgical Fertility Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 CooperSurgical Fertility Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 CooperSurgical Fertility Recent Developments
  • 11.6 Shreya Life Sciences
    • 11.6.1 Shreya Life Sciences Corporation Information
    • 11.6.2 Shreya Life Sciences Overview
    • 11.6.3 Shreya Life Sciences Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Shreya Life Sciences Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Shreya Life Sciences Recent Developments
  • 11.7 Sun Pharmaceutical Industries
    • 11.7.1 Sun Pharmaceutical Industries Corporation Information
    • 11.7.2 Sun Pharmaceutical Industries Overview
    • 11.7.3 Sun Pharmaceutical Industries Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Sun Pharmaceutical Industries Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Sun Pharmaceutical Industries Recent Developments
  • 11.8 CBC Pharma
    • 11.8.1 CBC Pharma Corporation Information
    • 11.8.2 CBC Pharma Overview
    • 11.8.3 CBC Pharma Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 CBC Pharma Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 CBC Pharma Recent Developments
  • 11.9 STEMCELL Technologies
    • 11.9.1 STEMCELL Technologies Corporation Information
    • 11.9.2 STEMCELL Technologies Overview
    • 11.9.3 STEMCELL Technologies Hyaluronidase Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 STEMCELL Technologies Hyaluronidase Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 STEMCELL Technologies Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Hyaluronidase Industry Chain Analysis
  • 12.2 Hyaluronidase Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Hyaluronidase Production Mode & Process
  • 12.4 Hyaluronidase Sales and Marketing
    • 12.4.1 Hyaluronidase Sales Channels
    • 12.4.2 Hyaluronidase Distributors
  • 12.5 Hyaluronidase Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Hyaluronidase Industry Trends
  • 13.2 Hyaluronidase Market Drivers
  • 13.3 Hyaluronidase Market Challenges
  • 13.4 Hyaluronidase Market Restraints

14 Key Findings in The Global Hyaluronidase Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer